141 related articles for article (PubMed ID: 28589183)
1. The clinicopathologic characteristics and prognostic factors of gastroesophageal junction tumors according to Siewert classification.
Ustaalioğlu BBÖ; Tilki M; Sürmelioğlu A; Bilici A; Gönen C; Ustaalioğlu R; Balvan Ö; Aliustaoğlu M
Turk J Surg; 2017; 33(1):18-24. PubMed ID: 28589183
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].
Shi GD; Luo ZL; Fu MY; Tian D; Zhang L; Zhang KP
Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):916-21. PubMed ID: 25623766
[TBL] [Abstract][Full Text] [Related]
3. Impact of the Siewert Classification on the Outcome of Patients Treated by Preoperative Chemoradiotherapy for a Nonmetastatic Adenocarcinoma of the Oesophagogastric Junction.
Moureau-Zabotto L; Teissier E; Cowen D; Azria D; Ellis S; Resbeut M
Gastroenterol Res Pract; 2015; 2015():404203. PubMed ID: 26448741
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of survival and prognosis of Siewert Ⅱ/Ⅲ esophagogastric junction adenocarcinoma patients with non-operative acute upper gastrointestinal hemorrhage].
Tian L; Yu L
Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(24):1881-1885. PubMed ID: 32575932
[No Abstract] [Full Text] [Related]
5. Adjuvant chemoradiotherapy
Kang WZ; Shi JM; Wang BZ; Xiong JP; Shao XX; Hu HT; Jin J; Tian YT
World J Gastrointest Oncol; 2022 Aug; 14(8):1540-1551. PubMed ID: 36160743
[TBL] [Abstract][Full Text] [Related]
6. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
[TBL] [Abstract][Full Text] [Related]
7. Comparison of survival outcomes between transthoracic and transabdominal surgical approaches in patients with Siewert-II/III esophagogastric junction adenocarcinoma: a single-institution retrospective cohort study.
Zhang W; Chen X; Liu K; Yang K; Chen X; Zhao Y; Zhao Y; Chen J; Chen L; Hu J
Chin J Cancer Res; 2016 Aug; 28(4):413-22. PubMed ID: 27647969
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
[TBL] [Abstract][Full Text] [Related]
9. Laparoscopic-assisted versus open total gastrectomy for Siewert type II and III esophagogastric junction carcinoma: a propensity score-matched case-control study.
Huang CM; Lv CB; Lin JX; Chen QY; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Cao LL; Lin M; Tu RH
Surg Endosc; 2017 Sep; 31(9):3495-3503. PubMed ID: 27981384
[TBL] [Abstract][Full Text] [Related]
10. Differences in prognosis of Siewert II and III oesophagogastric junction cancers are determined by the baseline tumour staging but not its anatomical location.
Kulig P; Sierzega M; Pach R; Kolodziejczyk P; Kulig J;
Eur J Surg Oncol; 2016 Aug; 42(8):1215-21. PubMed ID: 27241921
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological Characteristics and Prognostic Factors of Patients with Siewert Type II Esophagogastric Junction Carcinoma: A Retrospective Multicenter Study.
Matsuda T; Kurokawa Y; Yoshikawa T; Kishi K; Misawa K; Ohi M; Mine S; Hiki N; Takeuchi H
World J Surg; 2016 Jul; 40(7):1672-9. PubMed ID: 26928855
[TBL] [Abstract][Full Text] [Related]
12. Genomic Landscape of Adenocarcinomas Across the Gastroesophageal Junction: Moving on from the Siewert Classification.
Nakauchi M; Walch HS; Nussenzweig S; Carr R; Vos E; Berger MF; Schultz N; Janjigian Y; Wu A; Tang L; Shah P; Jones DR; Coit D; Strong VE; Molena D; Sihag S
Ann Surg; 2024 Jun; ():. PubMed ID: 38841851
[TBL] [Abstract][Full Text] [Related]
13. The length of proximal margin does not influence the prognosis of Siewert type II/III adenocarcinoma of esophagogastric junction after transhiatal curative gastrectomy.
Feng F; Tian Y; Xu G; Liu S; Liu Z; Zheng G; Guo M; Lian X; Fan D; Zhang H
Springerplus; 2016; 5():588. PubMed ID: 27247885
[TBL] [Abstract][Full Text] [Related]
14. Comparison of preoperative concurrent chemoradiotherapy with chemotherapy alone in patients with locally advanced siewert II and III adenocarcinoma of the esophagogastric junction.
Ge X; Zhao Q; Song Y; Li J; Liu M; Bai W; Qiao X
Eur J Surg Oncol; 2018 Apr; 44(4):502-508. PubMed ID: 29395438
[TBL] [Abstract][Full Text] [Related]
15. Surgical approaches to adenocarcinoma of the gastroesophageal junction: the Siewert II conundrum.
Brown AM; Giugliano DN; Berger AC; Pucci MJ; Palazzo F
Langenbecks Arch Surg; 2017 Dec; 402(8):1153-1158. PubMed ID: 28803334
[TBL] [Abstract][Full Text] [Related]
16. Explored Risk Factors for Lymph Node Metastasis with Siewert II/III Adenocarcinoma of the Gastroesophageal Junction.
Zheng Z; Yin J; Wu HW; Li J; Cai J; Qin SQ; Zhang J; Yao HW; Li JS; Zhang ZT
Anticancer Res; 2017 Aug; 37(8):4605-4610. PubMed ID: 28739759
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic comparison of Siewert type II and III adenocarcinomas of the gastroesophageal junction.
Yuasa N; Miyake H; Yamada T; Ebata T; Nimura Y; Hattori T
World J Surg; 2006 Mar; 30(3):364-71. PubMed ID: 16485063
[TBL] [Abstract][Full Text] [Related]
18. Adenocarcinoma of the esophagogastric junction: the role of abdominal-transhiatal resection.
Carboni F; Lorusso R; Santoro R; Lepiane P; Mancini P; Sperduti I; Santoro E
Ann Surg Oncol; 2009 Feb; 16(2):304-10. PubMed ID: 19050964
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of the number of lymph nodes examined in node-negative Siewert type II esophagogastric junction adenocarcinoma.
Wu XN; Liu CQ; Tian JY; Guo MF; Xu MQ
Int J Surg; 2017 May; 41():6-11. PubMed ID: 28323156
[TBL] [Abstract][Full Text] [Related]
20. Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III Adenocarcinoma.
Mitchell KG; Ikoma N; Nelson DB; Maru DM; Erasmus JJ; Weston BR; Vaporciyan AA; Antonoff MB; Mehran RJ; Rice DC; Roth JA; Swisher SG; Sepesi B; Walsh GL; Correa AM; Das P; Blum MA; Badgwell BD; Hofstetter WL
Ann Thorac Surg; 2019 Sep; 108(3):845-851. PubMed ID: 31102632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
